You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 263 No. 21, June 6, 1990 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorials
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

When Does Diabetes Start?

Christopher D. Saudek, MD

JAMA. 1990;263(21):2934.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Diabetes causes multiple metabolic defects, and its complications attack multiple organ systems. But it is frustratingly difficult to pin down a specific link between these metabolic derangements and long-term complications. The venerable "control and complications controversy" persists because we keep looking for one answer, one simple relationship between glycemic control and diabetic complications. But why should the relationship be simple or linear? Why should the product of blood glucose and time necessarily cause, equally, such diverse end-organ damage as neuropathy, nephropathy, retinopathy, and accelerated atherosclerosis? Factors other than blood glucose are almost certainly involved.

It should not be surprising, then, that obesity, blood pressure, high serum lipid levels, and family history play a significant role in macrovascular complications. Coexisting risk factors are especially relevant in type II, non—insulin-dependent diabetes, because this disease confers the most risk for accelerated atherosclerosis and the risk is most difficult to correlate specifically with glycemia. . . . [Full Text PDF of this Article]


Author Affiliations

From the Division of Endocrinology and Metabolism, and the General Clinical Research Center, The Johns Hopkins University School of Medicine, Baltimore, Md.


Footnotes

Reprint requests to The Johns Hopkins Hospital, 600 N Wolfe St, Osier 576, Baltimore, MD 21205 (Dr Saudek).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.